losartan and sch 23390

losartan has been researched along with sch 23390 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Strassburg, CP; Tukey, RH	1
Aperia, A; Crambert, S; Di Ciano, L; Eklöf, AC; Ibarra, F; Li, D; Scott, L; Zelenin, S	1

Reviews

1 review(s) available for losartan and sch 23390

Article	Year
Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annual review of pharmacology and toxicology, 2000, Volume: 40 Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic	2000

Other Studies

1 other study(ies) available for losartan and sch 23390

Article	Year
Binding of losartan to angiotensin AT1 receptors increases dopamine D1 receptor activation. Journal of the American Society of Nephrology : JASN, 2012, Volume: 23, Issue:3 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Aortic Coarctation; Benzazepines; Cell Membrane; Cyclic AMP; Disease Models, Animal; HEK293 Cells; Humans; Hypertension; In Vitro Techniques; Kidney; Kidney Tubules, Proximal; Losartan; Male; Protein Binding; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Dopamine D1; Signal Transduction	2012

Article

Year

Binding of losartan to angiotensin AT1 receptors increases dopamine D1 receptor activation.

Journal of the American Society of Nephrology : JASN, 2012, Volume: 23, Issue:3

Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Aortic Coarctation; Benzazepines; Cell Membrane; Cyclic AMP; Disease Models, Animal; HEK293 Cells; Humans; Hypertension; In Vitro Techniques; Kidney; Kidney Tubules, Proximal; Losartan; Male; Protein Binding; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Dopamine D1; Signal Transduction

2012